Search Results 1021-1030 of 15400 for TNF

  1. A Study Of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, In Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) ...

  2. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  3. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  4. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  6. North American Prodromal Synucleinopathy (NAPS) Consortium - Mayo Clinic

    The purpose of this study is to establish a registry of RBD patients, develop quantitative biological and functional measures of synucleinopathy burden, and ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

    Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

  9. Patient Stories - Todd A. Kellogg, M.D. - Mayo Clinic

    The deadline to have twice the impact to advance healthcare research is May 15. Give Today · Find a doctor · Explore careers.

  10. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.